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Abstract 
Background: Development of transdiagnostic standardised measures of psychological 
distress have contributed to the development of practice based evidence networks. The 
translation and validation of such measures cross culturally is important if such research 
is to be generalised across health care systems in different countries.  
Method: Translation of the Clinical Outcomes in Routine Evaluation Outcome Measure  
(CORE-OM) from English into Icelandic was undertaken according to recommended 
protocols. The resulting instrument was evaluated for reliability and validity in three 
groups; patients undergoing psychological treatment in general practice (n= 289), 
psychiatric outpatients (n=98) and student controls (n=207). Clinical participants 
underwent diagnostic interview were the MINI-International Neuropsychiatric 
Interview were administered. The clinical participant also completed the CORE-OM 
and the Beck Depression and Anxiety Inventories before and after treatment. The 
transdiagnostic relationship between CORE-OM scores and scores on those diagnostic 
measures was assessed. 
Results: Good levels of validity, reliability and internal consistency were found for the 
CORE-OM and its domains and sensitivity to change over treatment shown.  As 
anticipated, the Risk domain had different characteristics than other domains. CORE-
OM scores correlated strongly with both BDI-II and BAI, particularly the problem 
domain. 
Conclusion: The Icelandic translation of the CORE-OM is psychometrically sound and 
can be applied in Icelandic mental health studies as it has been in English speaking 
settings. Nevertheless the validity of the Icelandic version of the CORE-OM needs to 
further investigate in larger and more diverse samples 
Key words: 
CORE-OM, Psychometric properties, Transdiagnostic  
Key Practitioner Message 
•The psychometric properties of the Icelandic version of CORE-OM are comparable to 
the original English version  
•The results indicate transdiagnostic utility of the CORE-OM 
•The CORE-OM is a valuable instrument in outcome research on psychological 
treatment, specifically transdiagnostic treatment 
 
Introduction 
 
A lack of consensus on which measures to use for any particular construct complicates 
reviews of outcome research since scores have to be transformed for comparability and, 
it is not always clear that such transformations are psychometrically valid. Both 
researchers and clinicians have been concerned about this for several decades and since 
the 1970’s various attempts have been made to develop a core measure that clinicians 
can agree is reliable, valid and appropriate across common emotional 
disorders(Horowitcz, Strupp, Lambert & Elkin,1997) 
 
These attempts have not been without difficulties, one being that theoretical neutrality 
of the measure was considered a condition for a widespread consensus but choice of 
items tends to be linked to the theoretical stance of the author/s. However, progress was 
achieved in the 1990’s when a number of assessment instruments were developed, such 
as the Outcome Questionnaire system (OQ) (Lambert, Hansen & Harmon, 2010) 
Treatment Outcome Package (TOP)(Kraus & Castonguay, 2010) and the CORE 
system(Barkham et al., 1998; Evans et al., 2000; Evans et al., 2002). Of particular 
importance is the way in which the development and validation of such systems opened 
the way to the evaluation of studies that were either not diagnostically driven or 
spanned multiple diagnoses.  Such therapies have often been labelled transdiagnostic 
therapies and these approaches to mental health problems have gained increasing 
interest in resent years.  In such approaches the specific diagnosis is seen as less 
important and the specific cognitions, emotions and phenomenology the clients bring 
are more the focus of the therapy(Harvey, Watkins, Mansell, & Shafran, 2004).  
 
The CORE System consist of CORE-OM (a self-report outcome measure, long and 
short version) and CORE-A (a clinician rated assessment sheet filled out before and 
after treatment). CORE-OM is the focus of this paper and described in more detail in 
the measurements section. It was designed to be pantheoretical and not to be diagnosis 
specific. Studies have reported acceptability, reliability, validity in terms of 
clinical/non-clinical differentiation and sensitivity to change.  Convergent validity with 
diagnosis specific measures and other non-specific measures has been shown and a 
score translation to and from the Becks Depression Inventory – second edition  (BDI-II) 
has been established for the English version(Evans et al., 2002). These parameters are 
explored for the Icelandic translation in this paper. 
 
However, no study we know of has explored the transdiagnostic issue of how the 
overall score and domain scores of the CORE-OM relate to different diagnostic 
measures in a multiple linear regression or partial correlation analysis. Such analyses 
show us (i) whether the diagnosis specific measure have equal and distinguishable 
covariance with the non-diagnostic measure or if one accounts for more of the shared 
variance than the other; and (ii) whether covariance is confined to the problem domain 
on the CORE-OM or more general. Extremely low levels of unique variance explained 
for one of the instruments might (although not conclusively) suggest that the CORE-
OM covers a wide ranges of symptoms common across different diagnoses which can 
be said to render it with transdiagnostic features. Such a measure would be appropriate 
as a primary measure in research on transdiagnostic treatment and even as secondary 
measure in research on a wide range of diagnosis specific treatments. Given such results 
it may be further hypothesised that the problem domain would be very important for 
such transdiagnostic features since the domain is designed to be equally symptom 
oriented as the BDI-II and the Becks Anxiety Inventory (BAI). That could be tested in a 
similar but reverse fashion, i.e. by assessing which domain score explains the most 
variance of the BDI-II and the BAI, and then how much unique variance the other 
domains explain. These transdiagnostic features have been intrinsically assumed, but 
have to our knowledge not been investigated in this way yet. 
 
The psychometric properties of the CORE-OM in English in UK data have been shown 
to be excellent(Connell et al., 2007; Evans et al., 2002; Lyne, Barrett, Evans, & 
Barkham, 2006), internal consistency is high (Cronbach’s alpha of .94 for overall score 
in both non-clinical and clinical samples), and test retest stability of .90 in a student 
sample again for overall score(Evans et al., 2002). The validity of CORE–OM in terms 
of “caseness” is very good as is its discriminant validity shown in a large location 
difference between clinical and non-clinical samples. Results also showed good 
convergent validity and the CORE–OM correlates most highly with conceptually close 
measures, e.g. the BDI–II, (r = 0.81)(Leach et al., 2006) and the SCL–90–R, (r = 0.88). 
The CORE-OM is also sensitive to change and capable of detecting clinical change. 
Finally, the CORE-OM is well accepted by patients(Evans et al., 2002) and free to 
reproduce on paper without licence fees.   
 
The measure in English has been evaluated in a range of settings in the UK and South 
Africa(Campbell & Young 2011). Barkham, Culverwell, Spindler,Twigg and Connell 
(2005) found that the psychometric properties of the CORE-OM in an older adult UK 
population were acceptable and overall similar to the psychometric properties of the 
instrument in the general population in UK though clinical means were lower in the 
older adult sample than in younger clinical samples. 
 
Barkham et al.(2001) also provided benchmark data, i.e. baseline scores from 39 
secondary healthcare services, to which other service profiles can be compared. UK 
National benchmarks and a list of over 100 publications that have used the system can 
be accessed on the CORE system’s web site, www.coreims.co.uk.  
 
The CORE-OM has been now translated into 20 languages, Norwegian, Welsh, 
Spanish, Portuguese, German, Dutch, Greek, Italian, Danish, Icelandic, Swedish, Polish, 
Finnish, Lithuanian, Slovak, Turkish, Croatian, Albanian and Gujarati. The 
psychometric properties of the Italian, Slovak, Swedish, Lithuanian, Japanese and 
Portugalete translations have been published to date.  The psychometric properties of 
the Italian version of the CORE-OM were good(Palmieri et al., 2009). The same was 
true for the Swedish version (Elfström, Evans, Lundgern, Johansson, Hakeberg, & 
Lundgern, 2012) as well as the The Slovak version (Gampe, Bieščad, Balúnová-
Labaničová, Timul’ák,  & Evans, 2007), Japanies version (Uji, Sakamoto, Adachi & 
Kitamura, 2011) and the Lithuanian version (Viliū nienė et al, 2012). The Interal 
reliability in in the Portugalish version of CORE –OM was good in Sales, Molerio, 
Evans and Alves (2011) study. 
 
The Icelandic version of CORE-OM  
The idea of practice research networks (PRN) in other countries, using the same primary 
measure that is free to reproduce, is an attractive one and would support empirical 
exploration of practice similarities and differences between countries. The team that 
developed the CORE system had that in mind when they defined necessary features for 
such a measure, and they envisioned that it would be translated to other 
languages(Barkham et al., 1998; Evans, et al., 2000). They therefore established some 
rules for the translation process to ensure comparability between translations. Those 
ground rules are evolving but involve: a) multiple forward translations, b) holding a 
focus group comparing those translations with a member of the original author group 
present in the room and answering questions about the intention behind aspects of the 
measure or about the English, c) the translators should work with at least one mental 
healthcare professional, and d) input should be obtained from at least one service user 
who speaks both English and the target language. The Icelandic version of the CORE 
system was translated according to these ground rules and in close collaboration with 
one representative from the CORE system (CE). It was translated by a team of clinical 
psychologists and psychiatrists in addition to a professional translator. 
 
The present study reports psychometric data on the Icelandic version of the CORE-OM, 
specifically internal reliability, test-retest reliability, convergent validity, discriminant 
validity and sensitivity to change. Particular attention is paid to relationships with 
measures of anxiety and of depression to throw light on the transdiagnostic aspirations 
of the measure, which to our knowledge has not been explored in this way before. 
 
Method 
Participants 
The study included 594 adult participants comprising three samples, one non-clinical 
sample and two clinical samples. The non-clinical sample consisted of 207 university 
students from two different department, department of law and department of 
psychology.  Oft the 207 students, 71 (34%) were males and 136 (66%) females, with 
mean ages 22.9 and 22.5 years respectively. The students had no knowledge about 
CORE-OM prior to the administration All students were approached twice during 
lecture two weeks apart. There were no exclusion criteria for this sample.   
 
The two clinical samples consist of primary care patients and psychiatric out-patients, 
respectively, both experiencing psychiatric problems, primarily mood and anxiety 
disorders. Frequencies of psychiatric problems, evaluated with The MINI-International 
Neuropsychiatric Interview (see more information in measurement selection),  in the 
two clinical samples can be seen in table 1.  All participants in the clinical samples 
attended 5 week transdiagnostic cognitive behavioral group therapy. The group therapy 
was carried out as a part of standard care both in primary care and out-patients ward at 
the university hospital.  Exclusion criteria for treatment were age under 18 years, 
current psychotic symptoms, current self-reported substance use dependence or obvious 
signs of dementia or other generalized cognitive impairment.  
 
The primary care sample consists of 289 patients, 41 (14%) males and 248 (86%) 
females, with mean ages 41.2 and 40.3 years, respectively. All participants in the 
primary care sample were referred to the study by general practitioner. The psychiatric 
ward sample consists of 98 patients, 29 (30%) males and 69 (70%) females, with mean 
ages 35.4 and 35.3 years, respectively.  All participants in the psychiatric ward sample 
were referred to the study by medical doctors, psychiatrists, psychologist or psychiatric 
nurses 
 
Of the total sample, 577 (97%) participants returned appropriately completed 
questionnaires and were included in the study. The return for each sample was; 204 
(99%) university students, 279 (96%) primary care patients and 94 (96%) secondary 
care patients. Of the 204 students who completed the questionnaires satisfactorily the 
first time, 153 (74%) returned completed questionnaires two weeks later for test retest 
analysis. Of the 363 patients who completed the questionnaires satisfactorily at the first 
therapy session, 230 (63%) returned completed questionnaires at the end of treatment 
for sensitivity to change analysis. 
 
Measures 
Clinical Outcomes in Routine Evaluation – Outcome Measure (CORE-OM)(Evans et 
al., 2000; Evans et al., 2002) is a 34 item self-report instrument, with four domain 
scores, each reflecting a different aspect of life: well-being (four items), 
problems/symptoms (twelve items), life functioning (twelve items) and risk to self and 
others (six items). Items are scored on a five-point scale from 0 = not at all to 4 = all the 
time. Total scores range between 0 and 4 and higher scores reflect more severe 
problems.  
Beck Depression Inventory-II (BDI-II)(Beck, Steer & Brown, 1996) is a 21 item self-
report instrument used to measure depressive symptomatology. The twenty-one 
symptoms of depression are rated on a four-point scale (0-3), within the time frame of 
the past two weeks. The inventory had earlier been translated into Icelandic back 
translated to ensure accuracy. Psychometric evaluation of the Icelandic version of BDI-
II revealed adequate alpha coefficients in both student and patient sample (α = .91 and 
α=.93 respectively) and further confirmatory factor analysis supported the 
unidimensionality of the scale (Arnarson, Olason, Smári, & Sigurdsson, 2008). 
 
Beck Anxiety Inventory (BAI)(Beck, Epstein, Brown, & Steer, 1988) is a 21 item 
instrument designed to evaluate symptoms of clinical anxiety experienced during the 
past week. The items are rated on a four point scale (0-3). The instrument had earlier 
been translated into Iceland and back translated. A psychometric analysis showed that 
the Icelandic version of the BAI has acceptable psychometric properties(Sæmundsson et 
al., 2011) with alpha coefficients in both student and patient samples, i.e. α = .96 and 
α=.92, respectively.  
 
The MINI-International Neuropsychiatric Interview (MINI)(Sheehan et al., 1998) is a 
short structured diagnostic interview of mental disorders according to the diagnostic 
criteria of the DSM-IV and ICD-10. MINI was designed for multicentre clinical trials 
and epidemiological studies. Icelandic version of MINI has not yet been extensively 
studied although one preliminary study gives some support to its validity (Sigurðsson, 
2008). The English version of MINI has shown excellent reliability (Lecrubier et al., 
1997).  In Lecrubier et.al study (1997) kappa coefficients as well as sensitivity and 
specificity were good or very good for all diagnosis except GAD, bulimia and 
agoraphobia.  Inter-rater reliability and test retest reliability were also good in the same 
study. Table 1 lists MINI diagnostic categories and frequencies for each category.   
 
Table 1 about here 
Procedure 
The CORE-OM, the BDI-II and the BAI were administered to the students (Sample 1) 
during class hours and again two weeks later. An effort was made to make sure that 
there was a sufficient space provided between students to ensure privacy during 
responding. Students were not paid for their participation. The same measures were 
administered by clinical psychologist to the clinical samples (Samples 2 and 3) in intake 
interviews prior to the transdiagnostic CBT group therapy and again at the end of 
therapy. The MINI was only administered to the clinical samples. The therapy was 
developed by experienced clinical psychologists with extensive experience in delivering 
cognitive behavioural therapy. The treatment was delivered by two qualified clinical 
psychologists in each group, once a week for two hours for five weeks.  
 
Written informed consent for participation was obtained from all participants. 
Permission for the study was obtained from the National Bioethics Committee in 
Iceland (VSNb2005090003/03-15) and the study was approved by the Icelandic Data 
Protection Authority (S2602/2005). 
 
Results 
Age and gender 
Using Independent sample t  - test there were no significant main effects on CORE-OM 
for gender in all samples (Students: t (202) = 1.76, p > 0.05.  CI: -0,06 –to 0,23; 
Primary care: t (278) = -1.10, p > 0.05 CI: -0,34 to 0,10; Secondary care: t (92) = 0.38, 
p > 0.05, CI:-0,23 to 0,34 ).  The results indicate that non gender cut off scores should 
be used. The effects of age were explored. Scattergrams showed no evidence of non-
linear relationships and Pearson coefficients were calculated to test for simple 
correlation. Correlations were r = 0.06 in the secondary care sample, r = 0.25 in the 
primary care sample and r = 0.09 in the student sample.  Age therefore accounts for 
only 6% of the CORE-OM  variance in the primary care sample and less than 1% in the 
other samples. Student sample may suffer from restricted range. The results indicate that 
it is not necessary to adjust scores on the basis of either gender or age for the CORE-
OM in Iceland. 
 
Reliability  
Internal consistency 
A measure cannot have validity unless it has reliability.  Table 2 shows the Cronbach's 
alpha coefficients for all the CORE-OM scores. The alpha coefficients for the CORE-
OM total score are satisfactory in all samples. Those for the domain scores are also 
acceptable (range 0.78 – 0.95) for all the CORE-OM domain scores although being 
lower for the Risk domain (0.64 – 0.73).  
 
Table 2 about here 
 
Test – retest reliability 
In total 206 students were approached and 153 (74%) returned completed questionnaires 
from both administrations. In order for the results to be comparable to Evans et al. 
(2002), Spearman’s rhos were calculated. Test–retest correlations were high and 
acceptable for the CORE-OM Total score (rho = 0.80) and for all the CORE-OM 
domain scores (rho = 0. 75 - 0.78) except for the Risk domain (rho = 0.49). Low test-
retest on the Risk domain is not surprising when the distribution of scores on the 
domain is examined: reassuringly, of the 153 participants 127 scored zero on the pre-
test and 120 scored zero on the post-test. While such skewed results are expected for a 
non-clinical sample, they mean that small changes by a few participants have a large 
impact on stability parameters.  
 
Since the CORE-OM scores can be dichotomised using clinical/non-clinical cutting 
points (as described below), Kappa coefficients for test-retest reliability of the 
dichotomised scores were calculated and ranged from 0.61 – 0.71 for the total score and 
all the domain scores except for Risk (κ = 0.46). These values are categorised as 
“substantial” agreement for all but Risk, where agreement is moderate according to the 
Landis and Koch criteria (Landis & Koch, 1977). The Kappa and rho values are shown 
in Table 3. 
 Table 3 about here 
 
 
Validity 
Signal Detection Analysis / ROC Analysis 
Signal Detection Analysis (SDA) was conducted in the pooled clinical sample in order 
to map the CORE-OM scores to the MINI diagnosis. A ROC curve was obtained for all 
the scores and the total score. The Youden Index (J)(Youden, 1950) was used to 
determine the optimal cut-off values from the ROC analysis choosing the criterion score 
that maximises J. As another way to estimate the optimal cut-off value, the scores in 
non-clinical sample were compared to scores in the pooled clinical samples, using the 
Jacobson & Truax method C(Jacobson & Truax,1991) to estimate the cut-offs for 
clinical significant change (CSC). The results are summarized in Table 4.  
 
Table 4 about here 
 
The Risk domain was not included in the analysis because reliability analysis suggests 
that it is not a reliable scale (although it serves a clinical flag) and is therefore not 
suitable for a ROC analysis that i assumes a spectrum is measured against a 
dichotomous measure . Therefore it is wise to use the CORE-OM non-Risk total domain 
which consists of the total score minus the score for the Risk items to predict diagnosis 
on the MINI. The scores on the CORE Total scale are much lower than the non-Risk 
domain. When the two methods are compared  it can be seen that the criteria obtained 
by the CSC and ROC analysis are similar for the non-Risk domain, but not for the 
CORE Total score where the criteria obtained with CSC are lower than the criteria 
according toYouden’s  J.  
 
  
Convergent validity  
Pearson´s product moment correlation coefficients were computed between the CORE-
OM domain scores and the BDI-II and the BAI (see Table 5). Across the domain scores, 
correlations were highest between the conceptually related measures, i.e. the CORE 
Well-being, Problems and Functioning scores and the BDI-II and the BAI, showing 
acceptable convergent validity. The CORE-OM total score correlated strongly with the 
BDI-II (r=0.88) and somewhat less with the BAI (r=0.72). The CORE-OM domain 
scores other than the Risk score correlated strongly (between 0.81 and 0.85) with the 
BDI-II and somewhat less with BAI (between 0.63 and 0.74). The correlations between 
the Risk score and BAI and BDI-II were low (0.36 and 0.55 respectively). When the 
BDI-II was correlated with the CORE-OM controlling for the BAI, the correlation was 
0.79, but for the BAI controlling for the BDI-II, the correlation dropped much more, 
being 0.33.  
 
Table 5 about here 
 
These partial correlations suggest that the BDI-II accounts for much of the CORE-OM 
variation indicating that the CORE-OM measures features nonspecific to diagnostic 
categories. These results was further explored further by comparing two regression 
models; the first one entering only the BDI-II and the second one adding BAI to 
measure the unique additional explanatory power of BAI when controlled for BDI-II 
(planned stepwise regression). The measures were entered into the model in this order 
on grounds of the partial correlations above. Table 6 shows the results, which indicate 
that the BDI-II explains almost 80% of the variance of the CORE-OM total score. The 
additional explanation of the BAI is also significant, but only accounting for a further 
2%. Results are virtually the same for the domain scores and non-risk items total score. 
Because of this, the instrument that explained most of the variance of the CORE-OM, 
namely BDI-II, was used as the only reference instrument in all further analysis. 
 
Table 6 about here 
 
In order to examine the differential predictive power of individual domains of the 
CORE-OM for BDI-II, a stepwise linear regression was computed with the BDI-II as 
the dependent variable and the CORE-OM scores as independent variables. The results 
are presented in Table 7. The Table shows that the problem domain, which was 
designed to measure symptoms and complaints of those who suffer from depression and 
anxiety, covers almost all the variation and the other scores add little to the explained 
variance though each added a statistically significant covariation sequentially. The 
CORE-OM scores explained a total of 79% of the variance on the BDI-II, there of the 
Problem score explained 71%, indicating that the Problem domain has by far the 
strongest covariance with the BDI-II, the other domain scores adding only a further 9% 
though the gain through adding each was statistically significant at p<.001.    
 
Table 7 about here 
Discriminant validity 
The means and standard deviations for the CORE-OM domain scores are shown in 
Table 8. Mean scores were highest in the secondary care sample, followed by the 
primary care sample on all domain scores and the Total score. Lowest mean scores on 
the CORE–OM were in the non–clinical sample as expected. A one way Analysis of 
Variance (ANOVA) indicated significant main effects for groups on all the scores and 
the total score (F ranging from 15.39 to 97.31). In order to examine further the 
differences between the samples, a series of post hoc tests were conducted (with 
Tamhane corrections for unequal variances as there was significant heterogeneity of 
variance). There were significant differences between the non-clinical sample and both 
clinical samples for all the CORE-OM scores and the CORE-OM Total scale (p<0.05). 
The differences between the two clinical samples were however only found on the total 
scale and the Problem score (p<0.05). 
 
Table 8 about here 
 
Sensitivity to change 
A repeated measures ANOVA was carried out to assess sensitivity to change for non-
risk total score.  This was a 2x2 analysis; the patient group (primary care and secondary 
care) was the grouping variable and the pre-post comparison the within subject factor. 
There were significant main effects of repeats (F[1,241]=33.84, p<0.001) but no 
interaction between group and repeats (F[1, 241]=1.47, p=0.23).  This suggests that the 
CORE-OM non-risk total scores changed during treatment in both samples that 
indicates it´s utility as a primary measure in transdiagnostic treatment. Table 9 shows 
descriptive statistics and effect sizes for the domain scores and the total scores.    
 
Table 9 about here  
 
Discussion 
This paper presents the psychometric properties of the Icelandic version of the CORE-
OM. Our aim was to establish the reliability and validity of the Icelandic translation, to 
assess its sensitivity to change and to suggest appropriate cut-off scores. A secondary 
aim was to look into the possible utility of the instrument as a primary measure in 
transdiganostic treatment.  
 
The psychometric properties of the Icelandic version of the CORE-OM are as good as 
those found for the English version in UK data (Evans et al., 2002).  As in the UK data, 
the internal consistency and test-retest reliability were found to be good for both the 
non-clinical and the clinical samples, with the exception of the Risk domain score. 
These results are consistent with the CORE-OM results of Evans et al.(2002). The six 
items covering the Risk domain include four items addressing the risk of harming 
yourself and two items addressing the risk of harming another person. These two risk 
factors are not necessarily related which further reduces the internal reliability already 
constrained by having so few items.  
 
Test-retest reliability was good, though slightly lower than in the Evans et al.(2002) 
study. The Icelandic version of the CORE-OM proved to be  meaningfully stable over 
two week time interval in a substantial non-clinical sample.  One step not considered for 
the UK data was to use Kappa to explore the stability of a “clinical/non-clinical” 
dichotomisation of scores.  This too showed satisfactory reliability. 
 
As expected, the British cut off scores did not prove appropriate for use with the 
Icelandic translation. The total score and two out of four domain scores have lower cut 
off scores according to Youden’s J for the Icelandic data than the British cut offs 
calculated by CSC criterion. When that criterion is applied to the Icelandic data all 
domain scores and the total score have lower cut-off scores than in the 2002 British 
data(Evans et al., 2002). Firstly, this may reflect cultural differences between Icelandic 
people and British in how they present their mental health problems. Secondly, it may 
also reflect differences in demographic variation between the countries. The Icelandic 
population is so far more homogeneous regarding e.g. ethnic background and 
socioeconomic status, although in the last decade or so Iceland has become more and 
more multicultural. Thirdly, recent Icelandic epidemiological surveys of psychological 
health and morbidity are lacking and there may be a possibility that diagnostic base-
rates differ between the countries and different cut-off scores reflect that.  Finally, these 
differences may reflect different selection biases in the clinical samples since in Iceland 
people are not steered in different groups based on level of adjustment as in the British 
samples. 
 
However, the present study yielded a cut off score for the total score almost identical to 
the 2007 British data(Connell et al., 2007). In addition the cut-off scores for men and 
women in all three samples were almost identical in the Icelandic data which suggest 
that the same cut-off scores should be used for both genders. Connell et al.(2007) also 
recommended the use of a single cut off score, although the gender difference was still 
slightly larger than in the Icelandic data. 
 
Convergent validity of the Icelandic version of the CORE-OM appeared to be good with 
high correlations between it and the conceptually related measures, BDI-II and BAI.  
These results are highly consistent with the findings of Evans et al.(Evans et al., 2002) 
and suggest that the convergent validity of the Icelandic version of the CORE-OM is at 
least as good, as that of the original British version.  High inter-correlations were found 
between all the domains except the Risk domain in all three samples. The Risk domain 
had a slightly lower correlation with other domains in the student sample than in the 
clinical samples. Overall these findings are again similar to those of Evans et al. (2002) 
and Lyne et al.(2006) apart from the Risk domain, which had slightly higher 
correlations with other domains in the clinical samples than in student sample. A 
multiple regression analysis resulted in the BAI explaining close to nothing of the 
CORE-OM total score and all domain score variance, not already explained by the BDI-
II.  
As predicted the Problems domain accounts for the majority of the variance of the BDI-
II with much less variance being accounted for by the other domains. This is likely 
explained by the fact that the BDI-II is highly oriented towards the experience of mood 
problems and depressive symptoms. This is further underscored by its higher sensitivity 
than all other domain scores, including the non-risk items score and the total score. Any 
differential convergent validity for the Function, Well-being and Risk score validities 
will need testing by correlation against more specific measures such as quality of life 
(e.g., QOLS(Burckhardt, Anderson, Archenholtz, & Hägg, 2003) and work and social 
adjustment scales(Marks,1986). The validity of the Risk domain may be best assessed 
against the measurement of hopelessness and suicidal risk (e.g., the BHS and the BSI 
scales(Beck, Brown, Berchick, Stewart & Steer, 1990). Further research is needed 
though strong differential validity of the domain scores was never a design intention for 
the CORE-OM as noted above. 
 
There was a clear difference between the non-clinical and the clinical samples on all the 
scales and the total score. The differences between the two clinical samples showed that 
the secondary care sample scored significantly higher on the Total and the Problem 
scores, but not on the other scores, indicating that the CORE-OM differentiates 
acceptably between patients with mental health problems and the general population. 
The failure to detect differences on most domain scores between the two clinical 
samples may relate to the way services operate in Iceland. Everyone across the country 
has direct access to the Mental Health Services at Landspitali-The National University 
Hospital of Iceland in Reykjavik, irrespective of whether they have been referred by 
their GP or not.  In fact, patients have a choice where they seek mental health services 
and they are therefore not necessarily steered into the service by defined criteria. It is 
therefore probably unsurprising that no differences were observed between the primary 
and the secondary care samples. In keeping with this the analysis of sensitivity to 
change, comparing the primary and the secondary care samples, there was no evidence 
of either a group effect or a group X domain interaction, suggesting that the samples are 
more similar than different. The Icelandic version of the CORE-OM appears to be 
sensitive to changes following treatment. However there was no control group so it’s 
not certain that the changes are due to treatment rather than time.  
 
The similarity of our results to those of Evans et al.(2002) suggests that the Icelandic 
translation of the CORE–OM was successful and that Icelandic studies using the 
CORE-OM will be fully comparable with studies using the original British version. This 
will offer international comparison between treatment studies in Iceland and Britain. 
Moreover, the instrument is sensitive to change in a diagnostically heterogeneous 
sample. These results may seem to contrast with the results of the hierarchical 
regression analysis suggesting that the CORE-OM scores are well explained by the 
BDI-II with little added explanatory value of the BAI. This could indicate that the 
CORE-OM is mostly a measure of depression. However, the results may even more 
likely reflect the functional relationship between different emotional problems. A 
person with long lasting anxiety may suffer from decreased adjustment resulting in 
depressive symptoms and vise versa. A high correlation between measures of anxiety 
and depression are therefore to be expected and hence little additive explanatory value 
of variables added in later stages in hierarchical regression analysis such as those 
carried out here. These results taken together therefore suggest, at least tentatively, that 
the CORE-OM could be a feasible choice as a primary measure in efficacy studies of 
transdiagnostic treatment. 
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Table 1. MINI diagnostic categories and frequencies in pooled clinical sample.  
Disorder Time frame Frequencies(%) 
Major depressive episode Current (2 weeks), 
Recurrent 
45 
30 
MDE with melancholic features Current (2 weeks) 19 
Dysthymia Current (2 years) 18 
Suicidality Current (past month) 44 
Manic episode Current, Past 2 
Hypomanic episode Current, Past 2 
Panic Current (past month), 
Lifetime 
8 
Agoraphobia Current 3 
Social phobia Current (past month) 31 
OCD Current (past month) 7 
PTSD Current (past month) 7 
Alcohol dependence Past 12 months 8 
Alcohol abuse Past 12 months 1 
Substance dependence (Non 
alcohol) 
Past 12 months 2 
Substance abuse (Non alcohol) Past 12 months 0 
Psychotic Current 
 Lifetime 
0 
Mood disorder with psychotic 
features 
Current 1 
Anorexia nervosa Current (past 3 months) 0 
Bulimia nervosa Current (past 3 months) 2 
GAD Current (past 6 months) 44 
Antisocial personality disorder Lifetime 3 
Table 2. Internal reliability (Cronbach α) of the CORE-OM scales. 
 
 
  
  Non-Clinical sample Primary Care Secondary Care Pooled clinical samples 
Scale Alpha CI(95%) Alpha CI(95%) Alpha CI(95%) Alpha CI(95%) 
Well-being 0.84 0.82 - 0.86 0.79  0.75 - 0.83 0.78  0.70 - 0.85 0.79 0.75 - 0.82 
Problem/symptoms 0.91   0.90 - 0.92 0.87   0.84 - 0.89 0.88  0.84 - 0.91 0.87 0.85 - 0.89 
Functioning 0.88 0.87 - 0.90 0.88 0.85 - 0.90 0.84 0.79 - 0.87 0.87 0.85 - 0.89 
Risk 0.67 0.62 - 0.71 0.64  0.57 - 0.70 0.73 0.63 - 0.81 0.66 0.61 - 0.71 
Non-risk items 0.95 0.95 - 0.96 0.94   0.93 - 0.95 0.93 0.91 - 0.95 0.94 0.93 - 0.95 
All items 0.95 0.94 - 0.96 0.94 0.93 - 0.95 0.93 0.91 - 0.95 0.94 0.93 - 0.95 
Table 3. Test-retest reliability of the CORE-OM scales.  
 
                               Present study Evans et al. (2002) 
 
N Kappa CI(95%) Spearmans rho CI(95%) Spearmans rho (n =43) 
Well-being 152 0,63 0.47 -0.79 0,75 0.67 - 0.81 0,88 
Problem 148 0,64 0.48 - 0.80 0,77 0.69 - 0.82 0,87 
Function 149 0,61 0.44 - 0.78 0,75 0.67 - 0.81 0,87 
Risk 153 0,46 0.26 - 0.65 0,48 0.35 - 0.60 0,64 
       
Non-risk 
items 
151 0,63 0.42 - 0.84 0,71 0.62 - 0.78 0,91 
All items 148 0,71 0.59 - 0.83 0,8 0.73 - 0.84 0,9 
  
Table 4. Results of the Signal Detection Analysis and CSC. 
  ROC   CSC 
  AUC Criterion 
Sensitivity 
% 
Specificity 
% 
  Criterion 
Sensitivity 
% 
Specificity 
% 
Problems 0.80 1.42 72.1 78.7  1.33 80.1 64.0 
Well-being 0.79 1.75 61.1 81.3  1.35 74.2 64.0 
Function 0.83 1.33 63.1 86.7  1.08 77.4 69.3 
Non-risk 
items 
0.84 1.25 75.8 77.3  1.21 77.7 74.7 
All Items 0.83 0.62 81.7 70.3  0.98 54.0 86.5 
BAI 0.75 9,45 77.0 64.0  10.83 72.3 66.7 
BDI-II 0.82 19.50 63,4 86,7    12.66  84.8 57.3 
.  
  
Table 5. Correlations between the CORE-OM scales and the other self-report 
instruments. 
  BAI Well being Problems Functioning Risk All items Non-risk items 
Non-clinical sample        
BDI-II .68
** .83** .84** .82** .52** .89** .76** 
BAI  .64
** .72** .61** .38** .70** .63** 
Well Being   .85
** .81** .48** .91** .82** 
Problems    .80
** .49** .95** .86** 
Functioning     .48
** .93** .84** 
Risk      .59
** .09* 
All items       .86
** 
Primary care sample        
BDI-II .55
** .78** .77** .79** .51** .85** .82** 
BAI  .51
** .67** .53** .35** .63** .63** 
Well Being   .79
** .77** .50** .89** .87** 
Problems    .75
** .50** .93** .93** 
Functioning     .41
** .57** .54** 
Risk      .54
** .58** 
All items       .98
** 
Secondary care 
sample        
BDI-II .58
** .75** .78** .76** .53** .84** .82** 
BAI  .53
** .59** .47** .31** .58** .56** 
Well Being   .85
** .73** .41** .90** .88** 
Problems    .72
** .46** .94** .94** 
Functioning     .40
** .90** .87** 
Risk      .47
** .49** 
All items       .98
** 
pooled clinical sample        
BDI-II .55
** .78** .78** .79** .52** .85** .82** 
BAI  .51
** .64** .51** .34** .61** .61** 
Well Being   .81
** .76** .48** .89** .88** 
Problems    .74
** .49** .94** .93** 
Functioning     .35
** .54** .51** 
Risk      .52
** .56** 
All items            .98
** 
 
 
  
Table 6. BDI-II and BAI explained variance of CORE-OM total scale and domain 
scores. 
  R2-change B T 
Well-being       
     BDI-II 0.69 0.06 22.61* 
     BAI 0.01 0.01 4.51* 
Problems    
     BDI-II 0.72 0.05 22.44* 
     BAI 0.04 0.02 9.37* 
Function    
     BDI-II 0.68 0.05 22.70* 
     BAI 0.01 0.01 3.24* 
Risk    
     BDI-II 0.26 0.01 8.92* 
     BAI 0.00 0.00 1.49 
Non-risk Items    
     BDI-II 0.60 0.03 17.69* 
     BAI 0.02 0.01 5.24* 
All items    
     BDI-II 0.79 0.04 28.90* 
     BAI 0.02 0.01 7.46* 
*p< 0.01 
  
Table 7. CORE-OM domain scores incremental explained variance of BDI-II. 
  R2change B T 
BDI       
     Problems 0.71 4.79 8.43* 
     Function 0.06 4.99 8.57* 
     Well-being 0.02 3.01 6.01* 
     Risk 0.01 2.86 3.66* 
*p<0.001. 
 
  
Table 8. Descriptive statistics and ANOVA results for sample differences for the 
CORE-OM scales.  
  Non-clinical 
sample 
n = 204 
Primary care 
n = 279 
Secondary 
care 
n = 94 
  Pooled clinical 
sample 
n = 373 
Effect size 
clinical/non-
clinical 
Domain Mean (SD) Mean (SD) Mean (SD) F-
value* 
 Mean (SD)  
Well-being 0.89 (0.78) 1.89 (0.21) 2.11 (0.97) 89.808  1.94 (0.99) 0,11 
Problems 0.91 (0.68) 1.76 (0.82) 2.03 (0.82) 97.309  1.83 (0.82) 0,12 
Functioning 0.81 (0.52) 1.42 (0.79) 1.61 (0.71) 62.905  1.47 (0.77) 0,06 
Risk 0.07 (0.24) 0.21 (0.38) 0.29 (0.45) 15.385  0.23 (0.40) 1,03 
        
Non-risk items 0.86 (0.59) 1.64 (0.77) 1.81 (0.72) 86.677  1.69 (0.76) 0,15 
All items 0.72 (0.50) 1.39 (0.67) 1.58 (0.64) 93.515  0.94 (0.42) 0,65 
BDI-II 7.07(7.16) 20.95 (11.56) 25.11(11.84) 138.49  21.99 (11.76) 0,50 
BAI 6.90(7.4) 17.16 (12.66) 17.11(11.30) 56.08  17.16 (12.32) 0,55 
*All F-values are significant at the p<0.001 level. 
  
Table 9. Sensitivity to change. 
 
 
          First         Last  
  N Mean S.D. Mean S.D. Cohens d 
Problems 243 1.84 0.81 1.50 0.80 0.42 
Function 243 1.96 1.00 1.48 0.96 0.48 
Well-being 243 1.45 0.79 1.23 0.75 0.28 
Risk 244 0.23 0.38 0.17 0.35 0.16 
       
Non–Risk items 244 1.69 0.76 1.38 0.75 0.41 
All items 210 1.41 0.67 1.16 0.66 0.37 
